Prediction of misfolded proteins spreading in Alzheimer’s disease using machine learning and spreading models

Author:

Gherardini Luca1,Zajdel Aleksandra1,Pini Lorenzo2,Crimi Alessandro1

Affiliation:

1. Computer Vision Data Science Group, Sano centre for computational medicine , Czarnowiejska 36, Krakow 30-054 , Poland

2. Padua Neuroscience Center, University of Padua , Via 8 Febbraio, 2, Padua 35122 , Italy

Abstract

Abstract The pervasive impact of Alzheimer’s disease on aging society represents one of the main challenges at this time. Current investigations highlight 2 specific misfolded proteins in its development: Amyloid-$\beta$ and tau. Previous studies focused on spreading for misfolded proteins exploited simulations, which required several parameters to be empirically estimated. Here, we provide an alternative view based on 2 machine learning approaches which we compare with known simulation models. The first approach applies an autoregressive model constrained by structural connectivity, while the second is based on graph convolutional networks. The aim is to predict concentrations of Amyloid-$\beta$ 2 yr after a provided baseline. We also evaluate its real-world effectiveness and suitability by providing a web service for physicians and researchers. In experiments, the autoregressive model generally outperformed state-of-the-art models resulting in lower prediction errors. While it is important to note that a comprehensive prognostic plan cannot solely rely on amyloid beta concentrations, their prediction, achieved by the discussed approaches, can be valuable for planning therapies and other cures, especially when dealing with asymptomatic patients for whom novel therapies could prove effective.

Funder

Alzheimer's Disease Neuroimaging Initiative

National Institutes of Health

National Institute on Aging

National Institute of Biomedical Imaging and Bioengineering

Alzheimer's Association

Alzheimer's Drug Discovery Foundation

Araclon Biotech

BioClinica, Inc.

Bristol-Myers Squibb Company

CereSpir, Inc.

Meso Scale Diagnostics

NeuroRx Research

Neurotrack Technologies

Novartis Pharmaceuticals Corporation

Pfizer Inc.

Piramal Imaging

Canadian Institutes of Health Research

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Cognitive Neuroscience

Reference59 articles.

1. White matter damage in Alzheimer disease and its relationship to gray matter atrophy;Agosta;Radiology,2011

2. A review of harmonization strategies for quantitative pet;Akamatsu;Ann Nucl Med,2023

3. Temporal trajectories of in vivo tau and amyloid-$\beta$ accumulation in Alzheimer’s disease;Baek;Eur J Nucl Med Mol Imaging,2020

4. Functional imaging to guide network-based TMS treatments: toward a tailored medicine approach in Alzheimer’s disease;Bagattini;Front Neurosci,2021

5. Multi-site diffusion MRI harmonization;Billah;Zenodo,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3